Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

President Trump's new Executive Order takes aim at high drug prices. Pharmaceutical stocks ... Drug manufacturing giant Eli Lilly LLY is priced high at $730 per share, but it’s a stock that ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

Novo Nordisk and Eli Lilly , the leaders in the highly lucrative ... Roche says Trump's drug price order threatens its $50 billion US investment plans U.S. President Donald Trump's executive ...

Pfizer, on the other hand, with its improving growth prospects, rising estimates, cheaper valuation, and higher dividend ...

If Eli Lilly’s latest ad is any indication ... “Which is, literally, that we get to impact health, which is our way to impact humanity. I never understood if that’s so important, why do we have the ...

A miracle drug just wiped out WeightWatchers International’s (WW) 60-year empire. Here’s how Ozempic disrupted the weight ...